Anderson A B, Flint A P, Turnbull A C
J Endocrinol. 1975 Jul;66(1):61-70.
Maternal plasma progesterone levels in sheep may fall dramatically druing the last few days of gestation and following the administration of glucocorticoids to the foetus. To investigate the mechanism of the fall, metabolism of [3H] progesterone in vitro by ovin placental tissue was studied in five ewes before and after intra-foetal administration of dexamethasone in a dosage sufficient to induce parturition, and in one ewe after the spontaneous onset of labour at 143 days of gestation. Manual separation of maternal and foetal placental tissues showed that, in 11 out of 12 cases, the foetal and not the maternal placenta produced progesterone from pregnenolone in vitro. Total activities of cholesterol side-chain cleavage enzyme and 3beta-hydroxysteroid dehydrogenase in the foetal placenta were not influenced by intra-foetal dexamethasone. Befre administration of dexamethasone, homogenates of foetal placenta converted [3H] progesterone to 20alpha-hydroxy [3H]pregn-4-en-3-one in the presence of NADPH. Within 12 h of administration of dexamethasone, and after the natural onset of labour at 143 days, large amounts of 17alpha, 20alpha-dihydroxyI1pregn-4-en-3-one were formed form [3H]progesterone. Intra-foetal dexamethasone treatment also induced the formation of 17alpha, 20alpha-dihydroxy[3H]pregn-4-en-3-one by miced foetal placental tissue incubated with [3H]pregnenolone. This change in steroid metabolism did not occur in foetal placental tissue from a sham-operated animal receiving no dexamethasone. Assay of progesterone in foetal placentae showed that the increased fromation of 17alpha,20alpha-dihydroxypregn-4-en-3-one was unlikely to be caused by a change in the specific activity of added 3H-labelled precursor, although the production of 17alpha, 20alpha-dihydroxypregn-4-en-3-one in vitro increased at a time when both foetal placental and utero-ovarian venous levels of progesterone were decreasing in response to dexamethasone treatment. These observations indicate that intra-foetal dexamethasone treatment induces a placental 17alpha-hydroxylase enzyme, which is also present in foetal placental tissue after the spontaneous onset of labour at term.
绵羊孕期母血中孕酮水平在妊娠最后几天以及给胎儿注射糖皮质激素后可能会急剧下降。为了研究这种下降的机制,对5只母羊在给胎儿注射足以诱发分娩剂量的地塞米松前后,以及对1只在妊娠143天自然分娩发动后的母羊,研究了羊胎盘组织在体外对[3H]孕酮的代谢情况。人工分离母羊和胎儿胎盘组织显示,在12例中有11例,体外由孕烯醇酮产生孕酮的是胎儿胎盘而非母体胎盘。胎儿胎盘组织中胆固醇侧链裂解酶和3β - 羟基类固醇脱氢酶的总活性不受胎儿体内地塞米松的影响。在注射地塞米松之前,胎儿胎盘匀浆在NADPH存在的情况下将[3H]孕酮转化为20α - 羟基[3H]孕 - 4 - 烯 - 3 - 酮。在注射地塞米松后12小时内,以及在143天自然分娩发动后,大量的17α,20α - 二羟基 - 11 - 孕 - 4 - 烯 - 3 - 酮由[3H]孕酮形成。胎儿体内地塞米松处理还诱导了与[3H]孕烯醇酮一起孵育的混合胎儿胎盘组织形成17α,20α - 二羟基[3H]孕 - 4 - 烯 - 3 - 酮。在未接受地塞米松的假手术动物的胎儿胎盘组织中未发生这种类固醇代谢变化。对胎儿胎盘组织中孕酮的测定表明,17α,20α - 二羟基孕 - 4 - 烯 - 3 - 酮生成增加不太可能是由添加的3H标记前体的比活性变化引起的,尽管在胎儿胎盘和子宫 - 卵巢静脉中孕酮水平因地塞米松处理而下降时,体外17α,20α - 二羟基孕 - 4 - 烯 - 3 - 酮的生成增加。这些观察结果表明,胎儿体内地塞米松处理诱导了一种胎盘17α - 羟化酶,足月自然分娩发动后该酶也存在于胎儿胎盘组织中。